Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-05-13
Odyssey Therapeutics, Inc. (ODTX) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-13. 3 Form 8-K material event filings were reported by ODTX in the last 90 days. InsiderAlpha tracks every ODTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001882782 |
|---|
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-05-13 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LLC | Insider | J — Other acquisition / disposition | 61.8K | — | — | SEC | |
| Li Nan (LN) | Insider | P — Open-market purchase | 1.11M | $18.00 | $20.00M | SEC | |
| Li Nan (LN) | Insider | J — Other acquisition / disposition | 1.71M | — | — | SEC | |
| Glick Gary D | See Remarks | J — Other acquisition / disposition | 27.4K | — | — | SEC | |
| Opipari Anthony W. | See Remarks | J — Other acquisition / disposition | 7.0K | — | — | SEC | |
| Opipari Anthony W. | See Remarks | M — Option exercise | 541 | — | — | SEC | |
| Opipari Anthony W. | See Remarks | F — Tax withholding / forfeiture | 4 | $18.00 | $72 | SEC | |
| Chu Shelley | Insider | P — Open-market purchase | 11.1K | $18.00 | $200K | SEC | |
| LEIDEN JEFFREY M | Insider | J — Other acquisition / disposition | 28.7K | — | — | SEC | |
| LEIDEN JEFFREY M | Insider | M — Option exercise | 3.0K | — | — | SEC | |
| LEIDEN JEFFREY M | Insider | F — Tax withholding / forfeiture | 17 | $18.00 | $306 | SEC | |
| SR ONE CAPITAL MANAGEMENT, LLC | Insider | J — Other acquisition / disposition | 474.0K | — | — | SEC | |
| SR ONE CAPITAL MANAGEMENT, LLC | Insider | J — Other acquisition / disposition | 139.4K | — | — | SEC | |
| SR ONE CAPITAL MANAGEMENT, LLC | Insider | J — Other acquisition / disposition | 59.7K | — | — | SEC | |
| SR ONE CAPITAL MANAGEMENT, LLC | Insider | J — Other acquisition / disposition | 683.8K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Odyssey Therapeutics, Inc. (ODTX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LLC | 36 | $10.03M |
| Opipari Anthony W. | 10 | $72 |
| LEIDEN JEFFREY M | 9 | $100K |
| TPG GP A, LLC | 6 | $25.04M |
| Glick Gary D | 4 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ODTX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ODTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.